Addressing anhedonia to increase depression treatment engagement

被引:16
|
作者
Khazanov, Gabriela K. [1 ]
Forbes, Courtney N. [2 ]
Dunn, Barnaby D. [3 ]
Thase, Michael E. [1 ]
机构
[1] Crescenz Vet Affairs Med Ctr, Mental Illness Res Educ & Clin Ctr Vet Integrated, 3900 Woodland Ave, Philadelphia, PA 19104 USA
[2] Univ Toledo, Dept Psychol, Toledo, OH 43606 USA
[3] Univ Exeter, Mood Disorders Ctr, Exeter, Devon, England
关键词
anhedonia; depression; positive valence systems; reward; treatment engagement; MENTAL-HEALTH TREATMENT; BEHAVIORAL ACTIVATION TREATMENT; PRIMARY-CARE; COLLABORATIVE CARE; DECISION-MAKING; UNITED-STATES; TREATMENT ATTENDANCE; IMPROVE TREATMENT; ANXIETY; PSYCHOTHERAPY;
D O I
10.1111/bjc.12335
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Anhedonia, or reward system dysfunction, is associated with poorer treatment outcomes among depressed individuals. The role of anhedonia in treatment engagement, however, has not yet been explored. We review research on components of reward functioning impaired in depression, including effort valuation, reward anticipation, initial responsiveness, reward learning, reward probability, and reward delay, highlighting potential barriers to treatment engagement associated with these components. We then propose interventions to improve treatment initiation and continuation by addressing deficits in each component of reward functioning, focusing on modifications of existing evidence-based interventions to meet the needs of individuals with heightened anhedonia. We describe potential settings for these interventions and times at which they can be delivered during the process of referring individuals to mental health treatment, conducting intakes or assessments, and providing treatment. Additionally, we note the advantages of using screening processes already in place in primary care, workplace, school, and online settings to identify individuals with heightened anhedonia who may benefit from these interventions. We conclude with suggestions for future research on the impact of anhedonia on treatment engagement and the efficacy of interventions to address it. Practitioner points Many depressed individuals who might benefit from treatment do not initiate it or discontinue early. One barrier to treatment engagement may be anhedonia, a core symptom of depression characterized by loss of interest or pleasure in usual activities. We describe brief interventions to improve treatment engagement in individuals with anhedonia that can be implemented during the referral process or early in treatment. We argue that interventions aiming to improve treatment engagement in depressed individuals that target anhedonia may be particularly effective.
引用
收藏
页码:255 / 280
页数:26
相关论文
共 50 条
  • [21] Anhedonia and dopamine activity in depression
    Duval, Fabrice
    Mokrani, Marie-Claude
    Erb, Alexis
    Gonzalez, Felix
    Danila, Vlad
    [J]. PSYCHONEUROENDOCRINOLOGY, 2019, 107 : 41 - 41
  • [22] Anhedonia and dopamine function in depression
    Duval, Fabrice
    Mokrani, Marie-Claude
    Lopera, Felix Gonzales
    Diep, Than Son
    Pereira, Pedro Braccini
    [J]. BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 203S - 203S
  • [23] Anhedonia in depression and schizophrenia: A reexamination
    Romney, DM
    Candido, CL
    [J]. JOURNAL OF NERVOUS AND MENTAL DISEASE, 2001, 189 (11) : 735 - 740
  • [24] ANHEDONIA, DEPRESSION, AND SUICIDAL IDEATION
    LOAS, G
    FREMAUX, D
    GAYANT, C
    BOYER, P
    [J]. PERCEPTUAL AND MOTOR SKILLS, 1995, 80 (03) : 978 - 978
  • [25] IS ANHEDONIA A GOOD MEASURE OF DEPRESSION
    SILVERSTONE, PH
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1991, 83 (04) : 249 - 250
  • [26] Anhedonia in unipolar and bipolar depression
    Proudnikova, X.
    Hode, Y.
    Gonzalez, F.
    Duval, F.
    [J]. EUROPEAN PSYCHIATRY, 2014, 29 (08) : 571 - 571
  • [27] IDENTIFYING DEPRESSION - THE SIGNIFICANCE OF ANHEDONIA
    SNAITH, RP
    [J]. HOSPITAL PRACTICE, 1993, 28 (9A): : 55 - 60
  • [28] Psychomotor retardation and anhedonia in depression
    Lemke, MR
    Puhl, P
    Koethe, N
    Winkler, T
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 1999, 99 (04) : 252 - 256
  • [29] Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole
    Lemke, MR
    Brecht, HM
    Koester, J
    Kraus, PH
    Reichmann, H
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 17 (02) : 214 - 220
  • [30] The prominence of anhedonia in treatment-resistant depression and links to dopamine receptor binding
    Rizvi, S.
    Strafella, A.
    Rusjan, P.
    Sproule, B.
    Kennedy, S.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S381 - S381